Oxford Biomedica plc (LON:OXB - Get Free Report)'s stock price hit a new 52-week high during trading on Friday . The company traded as high as GBX 446.01 ($5.79) and last traded at GBX 445 ($5.78), with a volume of 210719 shares. The stock had previously closed at GBX 428.50 ($5.56).
Analyst Upgrades and Downgrades
Separately, Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Oxford Biomedica from GBX 250 ($3.25) to GBX 380 ($4.93) and gave the stock a "hold" rating in a research note on Tuesday, September 24th.
Check Out Our Latest Research Report on Oxford Biomedica
Oxford Biomedica Trading Up 5.7 %
The company has a debt-to-equity ratio of 154.88, a current ratio of 2.35 and a quick ratio of 1.67. The firm has a market cap of £468.85 million, a price-to-earnings ratio of -309.03 and a beta of 1.09. The firm's fifty day moving average is GBX 364.95 and its 200-day moving average is GBX 329.83.
Oxford Biomedica Company Profile
(
Get Free Report)
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
See Also
Before you consider Oxford Biomedica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Biomedica wasn't on the list.
While Oxford Biomedica currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
